Immusoft’s steps to delivering a treatment using engineered B cells. (Screen grab from Immusoft’s website) Seattle biotech startup Immusoft has received approval to begin clinical trials of its novel strategy for treating genetic disease, the company announced Thursday. Immusoft says it’s the first to get permission to use engineered immune system cells called B cells…
